Targeted therapy for breast cancer is a reality at this time, and several new agents hold promise for expanding and refining the pool of patients likely to furtherbenefit from this approach in the near future. The ongoing significant improvements in understanding of the altered molecular events in cancer cells in general and breast cancer cells specifically, have led to an explosion of new targets and agents for clinical testing.